On-Demand Webinars

51. Reducing Macroeconomic Pressures On Clinical Trial Supply: Session 2 4/28/2023

    Join IRT industry veteran and drug supply expert Stefan Dürr for a discussion about how to reduce the impact of both traditional and emerging macroeconomic pressures on clinical trial supply.

52. Accelerating Rare Disease Drug Development With Wearable DHTs 12/8/2023

    Watch as experts from ActiGraph, Bellerophon Therapeutics, and IQVIA come together to explore the obstacles and potential breakthroughs in rare disease research.

53. The Hidden Cost of CRO Change Orders and How Sponsors Can Best Manage Them 7/24/2026

    Improve budget oversight, forecast costs more accurately, and maintain a clear audit trail to minimize surprises and streamline CRO change orders.

54. Developing An Effective Data Asset Strategy For Wearables 3/5/2021

    A panel of wearable technology experts from ActiGraph, Takeda, Bristol Myers Squibb, Roche, and the University of California, San Diego explore analytical and clinical validation of wearable technologies, the future of algorithms used in academic and clinical research, and more during this on-demand Spotlight Session from the 2020 CNS Summit.

55. IRT And Direct-To-Patient Trials 1/12/2022

    Want to know more about the growth and expansion of IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study.

56. Facilitate Widespread Outpatient Immunotherapy Treatments With DHTs 6/6/2025

    An expert panel explores how the industry leverages digital innovation to manage immunotherapy risks and critical next steps toward deploying scalable, technology-driven CRS monitoring solutions.

57. An Honest Assessment Of eCOAs From A Site Perspective 10/30/2023

    Listen to what sites have to say about the changing nature of COAs in clinical trials, including the usage of eCOA, its benefits, and ways to improve the technology.

58. 3 Ways To Unlock The Value Of Real-World Evidence 12/13/2022

    Tune in as Castor’s Director of Solutions Consulting Kristen Harnack illustrates how a modular approach to clinical technology can help you conduct an RWE study.

59. Leverage DHT Data As Patient-Centric Primary Endpoints 5/23/2023

    See how digital outcome measures of physical activity collected from ActiGraph technology as the primary endpoint in a pivotal cardiopulmonary trial were endorsed by the FDA, marking an important milestone. 

60. Agentic AI delivers Impact Now, Even With Messy Trial Data 7/30/2026

    Think your messy, siloed data means AI has to wait? Think again. See how agentic AI drives measurable value across clinical trials without waiting for perfect data.